Media

WASHINGTON – Today, the Blue Dog Coalition voted in support of the short-term Continuing Resolution (CR) (H.J.Res. 99) that funds the federal government until May 5, 2017.

Rep. Henry Cuellar (D-TX), Blue Dog Co-Chair for Communications, issued the following statement:

WASHINGTON – Today, the co-chairs of the fiscally responsible Blue Dog Coalition—Reps. Jim Costa (D-CA), Henry Cuellar (D-TX), and Dan Lipinski (D-IL)—issued the following statement regarding the Continuing Resolution to keep the government open:

"Since the founding of the Blue Dog Coalition, together, we have called for responsible governance. This includes keeping the government open and fully-functioning. We cannot continue to operate deadline-to-deadline, creating self-inflicted crises along the way.

Today, members of the fiscally responsible Blue Dog Coalition announced that Brooke Lillard has joined the Coalition's staff as Communications Director. In her official capacity, Lillard will be working directly with Blue Dog members and their staff to bring the bipartisan work that the Blue Dog Coalition is doing on behalf of the American public to the forefront of the larger political and policy conversations.

WASHINGTON – Today, the co-chairs of the fiscally responsible Democratic Blue Dog Coalition—Reps. Jim Costa (D-CA), Henry Cuellar (D-TX), and Dan Lipinski (D-IL)—­­released the following statement in response to President Donald Trump's tax reform plan:

"The Blue Dogs are committed to working with our colleagues across the aisle to improve the lives of all Americans and solve our nation's ongoing fiscal crisis.

Today, the Democratic Blue Dog Coalition welcomed new member Congressman Charlie Crist (D-FL).

Today, the Democratic Blue Dog Coalition endorsed the Lower Drug Costs Through Competition Act, which was introduced by Blue Dog Congressman Kurt Schrader (D-OR) and Congressman Gus Bilirakis (R-FL) last week.

Today, the Blue Dog Coalition endorsed the Taxpayers' Right to Know Act which passed in the House by voice vote. The bipartisan bill was spearheaded by Blue Dog Congressman Jim Cooper (TN-5), and a version of the bill passed the House unanimously last year. Under the bill, every federal agency will be required to publish an annual report card for each of its programs.

Washington – Today, while the House Oversight Committee holds a bipartisan hearing with officials from Mylan, titled “Reviewing the Rising Price of EpiPens,” the Blue Dog Coalition endorsed a bill that could prevent dramatic price hikes like that of the EpiPen. H.R. 4784, the Lower Drug Costs Through Competition Act helps streamline the FDA approval process on generic drugs, and encourages competition by providing incentives for more generics to come to the market.